IRBM
ERS Genomics and IRBM sign license agreement for CRISPR/Cas9
May 20, 2024Research and Development CRISPR/Cas9, ERS Genomics, IRBM, License Agreement, Pharmacy
ERS Genomics and IRBM have announced that they have entered into a non-exclusive CRISPR/Cas9 license agreement, granting IRBM access to …
Latest content
Medtronic secures CE Mark for new cardiac pacing portfolio
October 30, 2026
Dermatology leader Doncker is new Onicor CEO
October 29, 2026
October 28, 2026
